TipRanks

Joel Ackerman Insider Profile

11 Followers
Joel Ackerman, Director at Champions Oncology, holds 1.13M shares in Champions Oncology (Ticker: CSBR), holds 132.43K shares in DaVita (Ticker: DVA), holds 0.00 shares in Kindred Healthcare (Ticker: KND).
tipranks
Joel Ackerman

Joel Ackerman
Champions Oncology (CSBR)
Director

Ranked #18,454 out of 109,349 Corporate Insiders

Profitable Transactions

100%
4 out of 4 Profitable Transactions

Average Return

+28.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$31M
82.53%
17.47%
A breakdown of Joel Ackerman's holdings

Insider Roles

DaVita
(DVA)
CFO & Treasurer
Champions Oncology
(CSBR)
Director
Roles that Joel Ackerman holds in companies

Most Profitable Insider Trade

Stock:
Champions Oncology
(CSBR)
Rating:Informative Sell
Date:Oct 03, 2018 - Oct 03, 2019
Return:+59.10%
The most profitable trade made by Joel Ackerman

Joel Ackerman's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Champions Oncology
Oct 16, 2026
Director
Uninformative Buy
111.67K
$5.42M
KND
Kindred Healthcare
May 25, 2017
―
Uninformative Buy
―
$0.00
DaVita
May 11, 2026
CFO & Treasurer
Informative Sell
9.89M
$25.60M
List of latest transactions for each holding click on a transaction to see Joel Ackerman's performance on stock

Joel Ackerman insider profile FAQ

What is the percentage of profitable transactions made by Joel Ackerman?
The percentage of profitable transactions made by Joel Ackerman is 100%.
    What is the average return per transaction made by Joel Ackerman?
    The average return per transaction made by Joel Ackerman is 28.10%.
      What stocks does Joel Ackerman hold?
      Joel Ackerman holds: CSBR, KND, DVA stocks.
        What was Joel Ackerman’s latest transaction?
        Joel Ackerman latest transaction was an Uninformative Buy of $111.67K.
          What was Joel Ackerman's most profitable transaction?
          Joel Ackerman’s most profitable transaction was an Informative Sell of CSBR stock on October 3, 2018. The return on the trade was 59.10%.
            What is Joel Ackerman's role in Champions Oncology?
            Joel Ackerman's role in Champions Oncology is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.